Human resistin protects against endotoxic shock by blocking LPS–TLR4 interaction

Jessica C. Jang,Jiang Li,Luca Gambini,Hashini M. Batugedara,Sandeep Sati,Mitchell A. Lazar,Li Fan,Maurizio Pellecchia,Meera G. Nair
DOI: https://doi.org/10.1073/pnas.1716015114
IF: 11.1
2017-11-13
Proceedings of the National Academy of Sciences
Abstract:Significance Gram-negative bacterial sepsis is a life-threatening disease that is exacerbated by an uncontrolled immune response to the endotoxin lipopolysaccharide (LPS). Human resistin is a highly expressed cytokine in sepsis, where it is hypothesized to exacerbate inflammation. We identify an unexpected protective role for resistin in endotoxic shock. We use human resistin-expressing transgenic mice and human immune cell assays to show that resistin prevents LPS-induced mortality by blocking LPS binding to its receptor Toll-like receptor 4 (TLR4) and by promoting anti-inflammatory signaling. Helminth infection-induced resistin and treatment with recombinant resistin or resistin N-terminal peptides also inhibited LPS function. These studies report a protective function for resistin and identify the therapeutic potential of resistin-mediated anti-inflammatory pathways or resistin-based reagents in sepsis.
What problem does this paper attempt to address?